Assessment of Tuberculosis Intensified Case Finding and Isoniazid Preventive Therapy for People Living with HIV in Enugu State, Nigeria

Abstract

Tuberculosis (TB) has remained the leading cause of morbidity and mortality among people living with HIV (PLHIV). Nigeria 
has the highest incidence of TB/HIV co infection and HIV associated TB deaths in sub-Saharan Africa. Therefore, TB prevention 
among PLHIV is of utmost necessity. We assessed tuberculosis intensified case finding (ICF) cascade and isoniazid preventive 
therapy (IPT) for people living with HIV in healthcare facilities in Enugu State, Nigeria. It was a cross sectional study conducted 
between February and May, 2019. We reviewed a total of 993 folders of PLHIV in the nine health care facilities offering ART 
in the State. Data was collected with ICF data collection form adapted from literature. Percentages were used to analyse data and
their values compared using chi square statistic. Ninety-eight point eight per cent of PLHIV had their TB screen done and 
documented as at last visit to the clinic, 80% of those screened positive had documented TB diagnostic evaluation while 96.2%
of PLHIV with positive TB evaluation were placed on anti-TB treatment. Furthermore, 61.2 % of PLHIV had ever received a 
course of IPT. Significant differences were observed in TB screening by location and IPT administration by type of health care 
facility (p<.05). Shortage of staff and poor remuneration were the most reported factors affecting implementation. The gaps 
identified in the implementation of ICF cascade and IPT have implications for public health and education. To reduce TB burden 
among PLHIV, all stakeholders must be involved in TB/HIV activities.